Pompidou Group Platforms

Download Report

Transcript Pompidou Group Platforms

National Bureau for Drug Prevention
How to improve quality of treatment
services:
the perspectives of Pompidou Group
Piotr Jabłonski
Director of
National Bureau for Drug Prevention
Vilnius, October 18,2007
Content of the presentation
Council of Europe
Pompidou Group
Treatment Platform
Expert Group opinious and
recommendations on the quality of
treatment and care of drug users
Piotr Jabłoński, National Bureau for Drug Prevention
Council of Europe
Established in 1949
The eldest political organisation on
continent
Assambles 47 countries
Observers: Japan, Canada, Mexico, USA,
Vatican
Piotr Jabłoński, National Bureau for Drug Prevention
Activity aims:
Protecting human rights
Strenghtening parliamentary democracy and the
rule of law
Establishing cooperation of continental range in
social and legal practice of member’s countries
Promoting the European concious of identity
leaning on common values
Piotr Jabłoński, National Bureau for Drug Prevention
Warsaw Declaration (2005)
Promoting common, basic values:
- human rights, the rule of law, democracy
Strenghtening safety citizens of Europe:
- prevention of terrorism, organized crime,
human trading
Establishing international cooperation
Piotr Jabłoński, National Bureau for Drug Prevention
Pompidou Group
the Cooperation Group to Combat Drug Abuse
and Illicit Trafficking of Drugs
The intergovernmental body
Established in 1971 at the suggestion of the
French President George Pompidou
initialy: informed forum establish by 7 countries
(France, Belgium, Germany, Luxembourg,
Netherland, United Kingdom) sharing their
experience of drug abuse prevention and drug
trafficking
Piotr Jabłoński, National Bureau for Drug Prevention
in 1980 the Group was incorporated into the
institutional framework of the Council of
Europe
today: Pompidou Group is part of Directorate
General of Social Cohesion
Today, 35 countries are the member of the
Pompidou Group
in 1990, technical cooperation has been
extended to countries of central and eastern
Europe which are not members of the Group
Piotr Jabłoński, National Bureau for Drug Prevention
Pompidou Group mission
the Pompidou Group vital mission is to contribute to
the development of multidisciplinary, innovative,
effective and evidence – based drug policies in its
member states
the Pompidou Group supports the link between
policy, practice and science
the Pompidou Group focuses especially on
conditions of local implementation of drugs
programmes
Piotr Jabłoński, National Bureau for Drug Prevention
Pompidou Group provides a multidisciplinary forum at the
wilder European level enabling policy makers,
professionals and research to discuss and exchange
information and ideas on the whole range a drug
problems
The non – binding nature of the Group provides with the
opportunity for open and politically non – biding
discussion between all Pompidou Group stakeholders
Bridging role of Pompidou Group for both European Union
and non European Union countries and for neighbouring
countries in the Mediterranean region (Algieria, Tunisia,
Maroco)
Focus on ethical issues with regard to public policy, public
health, social cohesion, penal policy.
Piotr Jabłoński, National Bureau for Drug Prevention
Organization structure
The Ministerial Conference – the political
authority of the Pompidou Group
Pompidou Group Presidency
Permanent Correspondents
Bureau
Platforms
Secretariat
Piotr Jabłoński, National Bureau for Drug Prevention
Pompidou Group Platforms







Main functions of the Platform are to introduce practitioners
knowledge and experience into the policy making process and
to identification and promotion of examples of good practices
in successful implementation of policies
Work Program for period 2007 – 2010 comprises 6 platforms
prevention
treatment
criminal justice and regulatory issues
airports
the research
the ethics and human rights
multisectoral coordination
Piotr Jabłoński, National Bureau for Drug Prevention
Platform participant are nominated by the
Member States (practically by Permanent
Correspondents)
Platforms provide for consideration by
Permanent Correspondents and, ultimately,
Ministers; information about: current
experience, recent developments, trends,
patterns, barriers and challenges in
practice
Each platform is managed by Coordinator
Piotr Jabłoński, National Bureau for Drug Prevention
Treatment Platform
The aims of Expert Forum on Treatment are to
signal problems in day – to – day practice,
promote standards identify priorities and need
To improve the treatment and care of specific
group
To adapt treatment to new trends, substances
and patterns of consumption
To assess the results of different modalities of
consumption
To evaluate risk reduction interventions and
measures to reduce harm to society
Piotr Jabłoński, National Bureau for Drug Prevention
Thematic objectives with regard to
improve quality
To match the patient need with treatment system
and offer
To facilitate the accessibility to treatment by
obtaining more flexibility of existing services for
drug users
To take into account the role of alcohol as a
main component in poly – drug use
To involve and support families (especially those
related to multi – drug consumption)
Piotr Jabłoński, National Bureau for Drug Prevention
To promote evaluation of effectiveness and cost
efficiency of different treatment modalities
To promote the evidence – based treatment
methods
To improve the skills of professionals working
„on the ground”
To highlight the specific therapy problems link to
HIV/AIDS risk and infection
To ensure the continuity of treatment including
therapy in prison
Piotr Jabłoński, National Bureau for Drug Prevention
With regard to adapting treatment to involving
patterns of drug consumption Pompidou
Group signal the following needs:
The rigidity of care structure facing the
new patterns of consumption
The necessity to adapt current care
modalities and approaches
The requirement to improve the specific
training for professionals
Piotr Jabłoński, National Bureau for Drug Prevention
To consider essential role of providing
support for self – help group for drug users
and their families
To promote and develop the involvement of
general Practitioners and other medical
doctors, especially psychiatrists in the
treatment and care of drug users
The needs of „holistic” view of the therapy,
particularly in relations to associated
physical and psychiatric diseases
Piotr Jabłoński, National Bureau for Drug Prevention
Special topic – Treatment of young drug users
With regards to young drug consumers
Pompidou Group points out following
features:
Increase in the general consumption of drug
among young people and stabilization of the
more serious drug – related health problems
Growth in cannabis use – solely or associated to
alcohol to other illegal drugs
Lack of care programmes and services specially
adapted to young people
Piotr Jabłoński, National Bureau for Drug Prevention
Experts propose
To distinguish two groups of young drug users
with different requirements: those between the
ages of 14 and 20 years and those between 21
and 25 years
Treatment modalities should be designed in a
different ways according to the type of client
(occasional consumers, problematic drug users
addicts)
A particular effort to assess risk situation and
reach occasional drug users by the improvement
of communication skills must be deployed
Piotr Jabłoński, National Bureau for Drug Prevention
The cooperation between care structures, education
and social services should be improved
Continuity of therapy and mid and long – term follow
– up should be provided
The profiles and communication skills of therapists
and other professionals should be developed taking
into account the complexity of young clients’
requirements
The care programmes should include only realistic
and pragmatic approaches and strategies
Prior to the choice of the treatment modality of young
drug user a clear definition of its goals should be
clarified
Piotr Jabłoński, National Bureau for Drug Prevention
Mile stones of global care practice
(terminology)
Definitions – common language, common
understanding
Epidemiological basis – monitoring systems on
various levels: local, regional, national,
international
Context of other adolescent problems
Risk and protective factors
Contact with young people
Screening and assessment
Treatment and planning
Comorbiality
Piotr Jabłoński, National Bureau for Drug Prevention
Final remarks
Linking policy, practice and science
Pompidou Group promotes evidance –
based approaches, effective law
enforcements and judicial measures,
innovative drug prevention and drug
treatment models as well as ethical and
human rights issues.
Piotr Jabłoński, National Bureau for Drug Prevention